Basiliximab Intravenous and Ciprofloxacin Extended-Release Tablets
Determining the interaction of Basiliximab Intravenous and Ciprofloxacin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: ciprofloxacin
Brand name: Cipro, Cipro XR, Proquin XR, Cipro IV
Synonyms: Ciprofloxacin, Ciprofloxacin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Ciprofloxacin in 5% Dextrose
- Basiliximab Intravenous-Ciprofloxacin injection
- Basiliximab Intravenous-Ciprofloxacin Injection Concentrate
- Basiliximab Intravenous-Ciprofloxacin Intravenous
- Basiliximab Intravenous-Ciprofloxacin Oral Suspension
- Basiliximab Intravenous-Ciprofloxacin Tablets
- Ciprofloxacin Extended-Release Tablets-Bavencio
- Ciprofloxacin Extended-Release Tablets-Baxdela
- Ciprofloxacin Extended-Release Tablets-Baxdela (Delafloxacin Injection)
- Ciprofloxacin Extended-Release Tablets-Baxdela (Delafloxacin Tablets)
- Ciprofloxacin Extended-Release Tablets-Baxdela Intravenous
- Ciprofloxacin Extended-Release Tablets-Baycadron